← Home
Zimmer Biomet 
Healthcare & biotech / Orthopedic and musculoskeletal medical devices
Press Releases
| Date | Press release |
|---|---|
| 2025-04-21 09:00:00 | Zimmer Biomet Completes Acquisition Of Paragon 28 Transaction further strengthens company’s position in high-growth foot and ankle segment warsaw, ind., april 21, 2025 /prnewswire/ -- zimmer biomet holdings, inc. (\"zimmer biomet\"; nyse and six: zbh), a global medical technology leader, today announced it has completed the acquisition of paragon 28, inc. (\"paragon 28\"), a leading medical device company focused exclusively on the fast-growing foot and ankle orthopedic space. |
| 2025-04-10 07:30:00 | Zimmer Biomet Announces Webcast And Conference Call Of First Quarter 2025 Financial Results Warsaw, ind. , april 10, 2025 /prnewswire/ -- zimmer biomet holdings, inc. (nyse and six: zbh) today announced its first quarter earnings conference call will be webcast on monday, may 5, 2025, at 8:30 a.m. |
| 2025-04-02 12:47:00 | Paragon 28 Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Paragon 28, Inc. - Fna New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of paragon 28, inc. (nyse: fna) to zimmer biomet holdings, inc. (nyse: zbh). under the terms of the proposed transaction, shareholders of paragon will receive $13.00 in cash as well as a non-tradeable contingent value right, entitling the holder to receive up to $1.00 per share in cash if certain revenue mileston. |
| 2025-04-01 07:30:00 | Zimmer Biomet Receives Ce Mark Approval For Ribfix Advantage® Fixation System Expanding thoracic portfolio warsaw, ind., and zug, switzerland , april 1, 2025 /prnewswire/ -- zimmer biomet holdings, inc. (nyse: zbh and six: zbh), a global medical technology leader, today announced its ribfix advantage® fixation system has received ce mark certification – the first ce mark for an intrathoracic rib fixation system. |
| 2025-03-11 16:01:00 | Paragon 28 Announces Expiration Of Hsr Act Waiting Period For Pending Acquisition By Zimmer Biomet Under Hsr Act Englewood, colo.--(business wire)--paragon 28, inc. (nyse: fna) (“paragon 28” or “company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the expiration of the waiting period under the hart-scott-rodino antitrust improvements act of 1976 (the “hsr act”) in connection with the previously announced acquisition of paragon 28 by zimmer biomet holdings, inc. (nyse: zbh) (“zimmer biomet”). the expiration of the waiting period under the. |
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Legal